1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Rx to OTC Switches Revenue 1.4 Market Analysis by Type 1.4.1 Global Rx to OTC Switches Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Analgesics 1.4.3 Anti-infectives 1.4.4 Gastrointestinal Drugs 1.4.5 Others 1.5 Market by Application 1.5.1 Global Rx to OTC Switches Market Share by Application: 2020 VS 2026 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Coronavirus Disease 2019 (Covid-19): Rx to OTC Switches Industry Impact 1.6.1 How the Covid-19 is Affecting the Rx to OTC Switches Industry 1.6.1.1 Rx to OTC Switches Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Rx to OTC Switches Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Rx to OTC Switches Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Rx to OTC Switches Market Perspective (2015-2026) 2.2 Rx to OTC Switches Growth Trends by Regions 2.2.1 Rx to OTC Switches Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Rx to OTC Switches Historic Market Share by Regions (2015-2020) 2.2.3 Rx to OTC Switches Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Rx to OTC Switches Market Growth Strategy 2.3.6 Primary Interviews with Key Rx to OTC Switches Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Rx to OTC Switches Players by Market Size 3.1.1 Global Top Rx to OTC Switches Players by Revenue (2015-2020) 3.1.2 Global Rx to OTC Switches Revenue Market Share by Players (2015-2020) 3.1.3 Global Rx to OTC Switches Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Rx to OTC Switches Market Concentration Ratio 3.2.1 Global Rx to OTC Switches Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Rx to OTC Switches Revenue in 2019 3.3 Rx to OTC Switches Key Players Head office and Area Served 3.4 Key Players Rx to OTC Switches Product Solution and Service 3.5 Date of Enter into Rx to OTC Switches Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Rx to OTC Switches Historic Market Size by Type (2015-2020) 4.2 Global Rx to OTC Switches Forecasted Market Size by Type (2021-2026) 5 Rx to OTC Switches Breakdown Data by Application (2015-2026) 5.1 Global Rx to OTC Switches Market Size by Application (2015-2020) 5.2 Global Rx to OTC Switches Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Rx to OTC Switches Market Size (2015-2020) 6.2 Rx to OTC Switches Key Players in North America (2019-2020) 6.3 North America Rx to OTC Switches Market Size by Type (2015-2020) 6.4 North America Rx to OTC Switches Market Size by Application (2015-2020) 7 Europe 7.1 Europe Rx to OTC Switches Market Size (2015-2020) 7.2 Rx to OTC Switches Key Players in Europe (2019-2020) 7.3 Europe Rx to OTC Switches Market Size by Type (2015-2020) 7.4 Europe Rx to OTC Switches Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Rx to OTC Switches Market Size (2015-2020) 8.2 Rx to OTC Switches Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Rx to OTC Switches Market Size by Type (2015-2020) 8.4 Asia-Pacific Rx to OTC Switches Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Southeast Asia 9.1 Southeast Asia Rx to OTC Switches Market Size (2015-2020) 9.2 Rx to OTC Switches Key Players in Southeast Asia (2019-2020) 9.3 Southeast Asia Rx to OTC Switches Market Size by Type (2015-2020) 9.4 Southeast Asia Rx to OTC Switches Market Size by Application (2015-2020) 10 India 10.1 India Rx to OTC Switches Market Size (2015-2020) 10.2 Rx to OTC Switches Key Players in India (2019-2020) 10.3 India Rx to OTC Switches Market Size by Type (2015-2020) 10.4 India Rx to OTC Switches Market Size by Application (2015-2020) 11 Central & South America 11.1 Central & South America Rx to OTC Switches Market Size (2015-2020) 11.2 Rx to OTC Switches Key Players in Central & South America (2019-2020) 11.3 Central & South America Rx to OTC Switches Market Size by Type (2015-2020) 11.4 Central & South America Rx to OTC Switches Market Size by Application (2015-2020) 12 Key Players Profiles 12.1 Bayer 12.1.1 Bayer Company Details 12.1.2 Bayer Business Overview and Its Total Revenue 12.1.3 Bayer Rx to OTC Switches Introduction 12.1.4 Bayer Revenue in Rx to OTC Switches Business (2015-2020)) 12.1.5 Bayer Recent Development 12.2 C. H. Boehringer Sohn 12.2.1 C. H. Boehringer Sohn Company Details 12.2.2 C. H. Boehringer Sohn Business Overview and Its Total Revenue 12.2.3 C. H. Boehringer Sohn Rx to OTC Switches Introduction 12.2.4 C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2015-2020) 12.2.5 C. H. Boehringer Sohn Recent Development 12.3 GlaxoSmithKline 12.3.1 GlaxoSmithKline Company Details 12.3.2 GlaxoSmithKline Business Overview and Its Total Revenue 12.3.3 GlaxoSmithKline Rx to OTC Switches Introduction 12.3.4 GlaxoSmithKline Revenue in Rx to OTC Switches Business (2015-2020) 12.3.5 GlaxoSmithKline Recent Development 12.4 Johnson & Johnson 12.4.1 Johnson & Johnson Company Details 12.4.2 Johnson & Johnson Business Overview and Its Total Revenue 12.4.3 Johnson & Johnson Rx to OTC Switches Introduction 12.4.4 Johnson & Johnson Revenue in Rx to OTC Switches Business (2015-2020) 12.4.5 Johnson & Johnson Recent Development 12.5 Merck 12.5.1 Merck Company Details 12.5.2 Merck Business Overview and Its Total Revenue 12.5.3 Merck Rx to OTC Switches Introduction 12.5.4 Merck Revenue in Rx to OTC Switches Business (2015-2020) 12.5.5 Merck Recent Development 12.6 Novartis 12.6.1 Novartis Company Details 12.6.2 Novartis Business Overview and Its Total Revenue 12.6.3 Novartis Rx to OTC Switches Introduction 12.6.4 Novartis Revenue in Rx to OTC Switches Business (2015-2020) 12.6.5 Novartis Recent Development 12.7 Pfizer 12.7.1 Pfizer Company Details 12.7.2 Pfizer Business Overview and Its Total Revenue 12.7.3 Pfizer Rx to OTC Switches Introduction 12.7.4 Pfizer Revenue in Rx to OTC Switches Business (2015-2020) 12.7.5 Pfizer Recent Development 12.8 Sanofi 12.8.1 Sanofi Company Details 12.8.2 Sanofi Business Overview and Its Total Revenue 12.8.3 Sanofi Rx to OTC Switches Introduction 12.8.4 Sanofi Revenue in Rx to OTC Switches Business (2015-2020) 12.8.5 Sanofi Recent Development 13 Analyst's Viewpoints/Conclusions 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Disclaimer 14.3 Author Details

List of Tables Table 1. Rx to OTC Switches Key Market Segments Table 2. Key Players Covered: Ranking by Rx to OTC Switches Revenue Table 3. Ranking of Global Top Rx to OTC Switches Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Rx to OTC Switches Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Analgesics Table 6. Key Players of Anti-infectives Table 7. Key Players of Gastrointestinal Drugs Table 8. Key Players of Others Table 9. COVID-19 Impact Global Market: (Four Rx to OTC Switches Market Size Forecast Scenarios) Table 10. Opportunities and Trends for Rx to OTC Switches Players in the COVID-19 Landscape Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 12. Key Regions/Countries Measures against Covid-19 Impact Table 13. Proposal for Rx to OTC Switches Players to Combat Covid-19 Impact Table 14. Global Rx to OTC Switches Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Rx to OTC Switches Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Rx to OTC Switches Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Rx to OTC Switches Market Share by Regions (2015-2020) Table 18. Global Rx to OTC Switches Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Rx to OTC Switches Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Rx to OTC Switches Market Growth Strategy Table 24. Main Points Interviewed from Key Rx to OTC Switches Players Table 25. Global Rx to OTC Switches Revenue by Players (2015-2020) (Million US$) Table 26. Global Rx to OTC Switches Market Share by Players (2015-2020) Table 27. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2019) Table 28. Global Rx to OTC Switches by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Rx to OTC Switches Product Solution and Service Table 31. Date of Enter into Rx to OTC Switches Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 34. Global Rx to OTC Switches Market Size Share by Type (2015-2020) Table 35. Global Rx to OTC Switches Revenue Market Share by Type (2021-2026) Table 36. Global Rx to OTC Switches Market Size Share by Application (2015-2020) Table 37. Global Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 38. Global Rx to OTC Switches Market Size Share by Application (2021-2026) Table 39. North America Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 40. North America Key Players Rx to OTC Switches Market Share (2019-2020) Table 41. North America Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 42. North America Rx to OTC Switches Market Share by Type (2015-2020) Table 43. North America Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 44. North America Rx to OTC Switches Market Share by Application (2015-2020) Table 45. Europe Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Rx to OTC Switches Market Share (2019-2020) Table 47. Europe Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 48. Europe Rx to OTC Switches Market Share by Type (2015-2020) Table 49. Europe Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 50. Europe Rx to OTC Switches Market Share by Application (2015-2020) Table 51. Asia-Pacific Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 52. Asia-Pacific Key Players Rx to OTC Switches Market Share (2019-2020) Table 53. Asia-Pacific Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 54. Asia-Pacific Rx to OTC Switches Market Share by Type (2015-2020) Table 55. Asia-Pacific Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 56. Asia-Pacific Rx to OTC Switches Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Rx to OTC Switches Market Share (2019-2020) Table 59. Southeast Asia Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Rx to OTC Switches Market Share by Type (2015-2020) Table 61. Southeast Asia Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Rx to OTC Switches Market Share by Application (2015-2020) Table 63. India Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 64. India Key Players Rx to OTC Switches Market Share (2019-2020) Table 65. India Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 66. India Rx to OTC Switches Market Share by Type (2015-2020) Table 67. India Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 68. India Rx to OTC Switches Market Share by Application (2015-2020) Table 69. Central & South America Key Players Rx to OTC Switches Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Rx to OTC Switches Market Share (2019-2020) Table 71. Central & South America Rx to OTC Switches Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Rx to OTC Switches Market Share by Type (2015-2020) Table 73. Central & South America Rx to OTC Switches Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Rx to OTC Switches Market Share by Application (2015-2020) Table 75. Bayer Company Details Table 76. Bayer Business Overview Table 77. Bayer Product Table 78. Bayer Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 79. Bayer Recent Development Table 80. C. H. Boehringer Sohn Company Details Table 81. C. H. Boehringer Sohn Business Overview Table 82. C. H. Boehringer Sohn Product Table 83. C. H. Boehringer Sohn Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 84. C. H. Boehringer Sohn Recent Development Table 85. GlaxoSmithKline Company Details Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline Product Table 88. GlaxoSmithKline Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 89. GlaxoSmithKline Recent Development Table 90. Johnson & Johnson Company Details Table 91. Johnson & Johnson Business Overview Table 92. Johnson & Johnson Product Table 93. Johnson & Johnson Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 94. Johnson & Johnson Recent Development Table 95. Merck Company Details Table 96. Merck Business Overview Table 97. Merck Product Table 98. Merck Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 99. Merck Recent Development Table 100. Novartis Company Details Table 101. Novartis Business Overview Table 102. Novartis Product Table 103. Novartis Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 104. Novartis Recent Development Table 105. Pfizer Company Details Table 106. Pfizer Business Overview Table 107. Pfizer Product Table 108. Pfizer Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 109. Pfizer Recent Development Table 110. Sanofi Business Overview Table 111. Sanofi Product Table 112. Sanofi Company Details Table 113. Sanofi Revenue in Rx to OTC Switches Business (2015-2020) (Million US$) Table 114. Sanofi Recent Development Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Global Rx to OTC Switches Market Share by Type: 2020 VS 2026 Figure 2. Analgesics Features Figure 3. Anti-infectives Features Figure 4. Gastrointestinal Drugs Features Figure 5. Others Features Figure 6. Global Rx to OTC Switches Market Share by Application: 2020 VS 2026 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Rx to OTC Switches Report Years Considered Figure 11. Global Rx to OTC Switches Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Rx to OTC Switches Market Share by Regions: 2020 VS 2026 Figure 13. Global Rx to OTC Switches Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Rx to OTC Switches Market Share by Players in 2019 Figure 16. Global Top Rx to OTC Switches Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rx to OTC Switches as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Rx to OTC Switches Revenue in 2019 Figure 18. North America Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Asia-Pacific Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Rx to OTC Switches Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Bayer Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 26. C. H. Boehringer Sohn Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. C. H. Boehringer Sohn Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 28. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. GlaxoSmithKline Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 30. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Johnson & Johnson Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Merck Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Novartis Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Pfizer Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 38. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Sanofi Revenue Growth Rate in Rx to OTC Switches Business (2015-2020) Figure 40. Bottom-up and Top-down Approaches for This Report Figure 41. Data Triangulation Figure 42. Key Executives Interviewed

Bayer C. H. Boehringer Sohn GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Sanofi